75.92Delayed Data As of 6:30pm ET |  -0.93 / -1.21%Today’s Change | 72.97 Today|||52-Week Range 109.42 | -10.30% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Pharmaceuticals: Generic | MARKET CAP $3.0B |
Company Description
Taro Pharmaceutical Industries Ltd. is engaged in the development, manufacturing, and marketing of prescribed and over-the-counter pharmaceutical products in the U.S., Canada, and Israel. Its products include semi-solids formulations, such as creams and ointments and other dosage forms such as liquids, capsules and tablets, in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. The company was founded in 1950 and is headquartered in Haifa Bay, Israel.
Employees
Shareholders
| Mutual fund holders | 5.96% |
| Other institutional | 5.09% |
| Individual stakeholders | 11.76% |
Top Executives
| There are no executives to display. |
-0.93 / -1.21%
